IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study

Journal Article Corrected proof IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study Get access Sizheng Steven Zhao, Sizheng Steven Zhao Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Correspondence to: Sizheng S. Zhao, Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester M13 9LJ, UK. E-mail: sizheng.zhao@manchester.ac.uk https://orcid.org/0000-0002-3558-7353 Search for other works by this author on: Oxford Academic PubMed Google Scholar Matthew C Baker, Matthew C Baker Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, USA https://orcid.org/0000-0002-0002-1907 Search for other works by this author on: Oxford Academic PubMed Google Scholar James B Galloway James B Galloway Centre for Rheumatic Diseases, King's College London, London, UK https://orcid.org/0000-0002-1230-2781 Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, kead613, https://doi.org/10.1093/rheumatology/kead613 Published: 17 November 2023 Article history Accepted: 14 November 2023 Published: 17 November 2023 Corrected and typeset: 30 November 2023